Humana Inc. Declares Quarterly Dividend of $0.89 (NYSE:HUM)

Humana Inc. (NYSE:HUM) declared a quarterly dividend on Thursday, October 24th,RTT News reports. Stockholders of record on Tuesday, December 31st will be paid a dividend of 0.885 per share by the insurance provider on Friday, January 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Tuesday, December 31st.

Humana has raised its dividend by an average of 12.3% per year over the last three years. Humana has a dividend payout ratio of 20.8% indicating that its dividend is sufficiently covered by earnings. Analysts expect Humana to earn $16.89 per share next year, which means the company should continue to be able to cover its $3.54 annual dividend with an expected future payout ratio of 21.0%.

Humana Stock Down 0.2 %

Humana stock opened at $255.64 on Friday. The business has a fifty day moving average price of $273.07 and a 200-day moving average price of $317.19. Humana has a 1-year low of $213.31 and a 1-year high of $475.00. The stock has a market capitalization of $30.78 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 2.15 and a beta of 0.53. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts forecast that Humana will post 16.14 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Morgan Stanley lifted their price objective on shares of Humana from $288.00 to $301.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Stephens reissued an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Barclays lifted their target price on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Finally, UBS Group cut their price target on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, October 4th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $300.50.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.